Pareidolias are a function of visuoperceptual impairment

por McCann, Emily, Lee, Soohyun, Coleman, Felicia, O’Sullivan, John D., Nestor, Peter J.
Publicado 2023

Measurement of blood–brain barrier permeability in acute ischemic stroke using standard first-pass perfusion CT data()

por Nguyen, Giang Truong, Coulthard, Alan, Wong, Andrew, Sheikh, Nabeel, Henderson, Robert, O'Sullivan, John D., Reutens, David C.
Publicado 2013

The effect of ageing on human lymphocyte subsets: comparison of males and females

por Yan, Jun, Greer, Judith M, Hull, Renee, O'Sullivan, John D, Henderson, Robert D, Read, Stephen J, McCombe, Pamela A
Publicado 2010

Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease

por Dissanayaka, Nadeeka N. W., Idu Jion, Farah, Pachana, Nancy A., O'Sullivan, John D., Marsh, Rodney, Byrne, Gerard J., Harnett, Paul
Publicado 2016

The CuePed Trial: How Does Environmental Complexity Impact Cue Effectiveness? A Comparison of Tonic and Phasic Visual Cueing in Simple and Complex Environments in a Parkinson's Dis...

por Marsh, Rodney, Cole, Michael H., Dissanayaka, Nadeeka N. W., Au, Tiffany R., Clewett, Sandra, O'Sullivan, John D., Silburn, Peter A.
Publicado 2019

Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study

por Evans, Andrew, Fung, Victor S.C., O'Sullivan, John D., Stell, Rick, White, Richard, Williams, David R., Femia, Samira, Onuk, Koray
Publicado 2020

A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation

por Jayabalan, Nanthini, Oronsky, Bryan, Cabrales, Pedro, Reid, Tony, Caroen, Scott, Johnson, Aishwarya M., Birch, Natalia A., O’Sullivan, John D., Gordon, Richard
Publicado 2023

Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease

por Pourzinal, Dana, Yang, Jihyun, Sivakumaran, Kumareshan, McMahon, Katie L., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J., Dissanayaka, Nadeeka N.
Publicado 2023

Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment

por Yang, Jihyun, McMahon, Katie L, Copland, David A, Pourzinal, Dana, Byrne, Gerard J, Angwin, Anthony J, O’Sullivan, John D, Dissanayaka, Nadeeka N
Publicado 2022

Levetiracetam for the treatment of mild cognitive impairment in Parkinson’s disease: a double-blind controlled proof-of-concept trial protocol

por Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O’Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan, Bakker, Arnold
Publicado 2023

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial

por Vivash, Lucy, Bertram, Kelly L, Malpas, Charles B, Marotta, Cassandra, Harding, Ian H, Kolbe, Scott, Fielding, Joanne, Clough, Meaghan, Lewis, Simon J G, Tisch, Stephen, Evans, Andrew H, O’Sullivan, John D, Kimber, Thomas, Darby, David, Churilov, Leonid, Law, Meng, Hovens, Christopher M, Velakoulis, Dennis, O’Brien, Terence J
Publicado 2021